DONSHEKIA MERCADEL: Open Payments
NPI 1801382106 · NEW ORLEANS, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$255 in 7 payments from 5 companies in 2025. Trend: 2023 $670 · 2024 $956 · 2025 $255
Food & beverage: $255
| Company | Payments | Amount |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 1 | $125 |
| ABBVIE INC. | 3 | $55 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $27 |
| Dexcom, Inc. | 1 | $26 |
| Vanda Pharmaceuticals Inc. | 1 | $21 |
Products named: Qelbree, VRAYLAR, Kerendia, Dexcom G6 Transmitter, UBRELVY, FANAPT.
Industry payments across LA — which companies pay providers there.
